Literature DB >> 10905753

Laboratory diagnosis of patients with acute chest pain.

I Penttilä1, K Penttilä, T Rantanen.   

Abstract

The enzyme activities of creatine kinase (CK), its isoenzyme MB (CK-MB) and of lactate dehydrogenase isoenzyme 1 (LD-1) have been used for years in diagnosing patients with chest pain in order to differentiate patients with acute myocardial infarction (AMI) from non-AMI patients. These methods are easy to perform as automated analyses, but they are not specific for cardiac muscle damage. During the early 90's the situation changed. First creatine kinase MB mass (CK-MB mass) replaced the measurement of CK-MB activity. Subsequently cardiac-specific proteins troponin T (cTnT) and troponin I (cTnI) appeared on the scene, displacing LD-1 analysis. However, troponin concentrations in blood increase only from four to six hours after onset of chest pain. Therefore a rapid marker such as myoglobin, fatty acid binding protein or glycogen phosphorylase BB could be used in early diagnosis of AMI. On the other hand, CK-MB isoforms alone may also be useful in rapid diagnosis of cardiac muscle damage. Myoglobin, CK-MB mass, cTnT and cTnI are nowadays widely used in diagnosing patients with acute chest pain. Myoglobin is not cardiac-specific and therefore requires supplementation with some other analyses such as troponins to support the myoglobin value. Troponins are very highly cardiac-specific. Only the sera of some patients with severe renal failure, which requires hemodialysis, have elevated cTnT and/or cTnI without there being any evidence of cardiac damage. On the other hand, the latest studies have shown that elevated troponin levels in sera of hemodialysis patients point to an increased risk of future cardiac events in a similar manner to the elevated troponin values in sera of patients with unstable angina pectoris. In addition, the bedside tests for cTnT and cTnI alone or together with myoglobin and CK-MB mass can be used instead of quantitative analyses in the diagnosis of patients with chest pain. These rapid tests are easy to perform and they do not require expensive instrumentation. For routine clinical laboratory practice we suggest that in diagnosis of patients with chest pain, myoglobin and CK-MB mass measurements should be performed whenever they are requested (24 h/day) and cTnT or cTnI on admission to the hospital and then 4-6 and 12 hours later.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905753     DOI: 10.1515/CCLM.2000.027

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Effect of hemodialysis on traditional and innovative cardiac markers.

Authors:  Martina Montagnana; Giuseppe Lippi; Nicola Tessitore; Gian Luca Salvagno; Giovanni Targher; Matteo Gelati; Antonio Lupo; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 3.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

Review 4.  An historical approach to the diagnostic biomarkers of acute coronary syndrome.

Authors:  Elisa Danese; Martina Montagnana
Journal:  Ann Transl Med       Date:  2016-05

5.  Quantification of intramyocardial hemorrhage volume using magnetic resonance imaging with three-dimensional T1-weighted sequence in patients with ischemia-reperfusion injury: a semi-automated image processing technique.

Authors:  Hideo Arai; Masateru Kawakubo; Ko Abe; Hikaru Hatashima; Kenichi Sanui; Hiroshi Nishimura; Toshiaki Kadokami
Journal:  Int J Cardiovasc Imaging       Date:  2019-09-14       Impact factor: 2.357

6.  Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients.

Authors:  Lei Wang; Liang Xie; Qigao Zhang; Xiaomin Cai; Yi Tang; Lijun Wang; Tao Hang; Jing Liu; Jianbin Gong
Journal:  Coron Artery Dis       Date:  2015-06       Impact factor: 1.439

7.  Cardiac troponin I as compared to troponin T for the detection of myocardial damage in horses.

Authors:  N Van Der Vekens; A Decloedt; S Ven; D De Clercq; G van Loon
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

8.  Label-free microcavity biosensors: steps towards personalized medicine.

Authors:  Dragos Amarie; James A Glazier
Journal:  Sensors (Basel)       Date:  2012-12-13       Impact factor: 3.576

9.  Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.

Authors:  Antoine Kossaify; Annie Garcia; Sami Succar; Antoine Ibrahim; Nicolas Moussallem; Mikhael Kossaify; Gilles Grollier
Journal:  Biomark Insights       Date:  2013-09-03

10.  Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study.

Authors:  Fulvio Morello; Anna Ravetti; Peiman Nazerian; Giovanni Liedl; Maria Grazia Veglio; Stefania Battista; Simone Vanni; Emanuele Pivetta; Giuseppe Montrucchio; Giulio Mengozzi; Mauro Rinaldi; Corrado Moiraghi; Enrico Lupia
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.